Skip to main content
Clinical Trials/NCT05923359
NCT05923359
Active, Not Recruiting
N/A

Realtime Diagnosis From Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation With Long Follow-Up (REGAL)

Mayo Clinic1 site in 1 country2,000 target enrollmentApril 10, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Mayo Clinic
Enrollment
2000
Locations
1
Primary Endpoint
Atrial fibrillation
Status
Active, Not Recruiting
Last Updated
3 months ago

Overview

Brief Summary

The purpose of this research is to test whether Apple Watch, used as a long-term monitoring device, can enable early detection of atrial fibrillation.

Registry
clinicaltrials.gov
Start Date
April 10, 2024
End Date
September 1, 2026
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Xiaoxi Yao

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Had a 10-second 12-lead ECG done at Mayo Clinic
  • Have a high AI-ECG risk score indicating a high likelihood of previously unrecognized AF
  • Men with CHA2DS2-VASc2 ≥2 or women with CHA2DS2-VASc ≥ 3

Exclusion Criteria

  • Diagnosed atrial fibrillation
  • Diagnosed dementia
  • Diagnosed end-stage kidney disease
  • History of intracranial bleeding
  • Have an implantable cardiac monitoring device, including a pacemaker, a defibrillator, or implanted loop recorder
  • Missing date of birth
  • Residence outside of the U.S. or missing address information

Outcomes

Primary Outcomes

Atrial fibrillation

Time Frame: 2 years

Number of participants diagnosed with atrial fibrillation

Secondary Outcomes

  • Ischemic stroke or systemic embolism events(2 years)
  • Major bleeding(2 years)
  • Change in individuals' maximum learning span(Baseline, 2 years)
  • Change in processing speed measure(Baseline, 2 years)
  • Mortality(2 years)

Study Sites (1)

Loading locations...

Similar Trials